Search Results - "Utracka, B."

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer by Cunningham, D., Sirohi, B., Pluzanska, A., Utracka-Hutka, B., Zaluski, J., Glynne-Jones, R., Koralewski, P., Bridgewater, J., Mainwaring, P., Wasan, H., Wang, J.-Y., Szczylik, C., Clingan, P., Chan, R. T. T., Tabah-Fisch, I., Cassidy, J.

“…Background: Oxaliplatin, 5-fluorouracil (5-FU), and leucovorin (LV) are standard first-line treatments for patients with metastatic colorectal cancer (mCRC)…”
Get full text

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients by Rogozińska-Szczepka, J., Utracka-Hutka, B., Grzybowska, E., Mąka, B., Nowicka, E., Smok-Ragankiewicz, A., Zientek, H., Steffen, J., Wojciechowska-Łącka, A.

“…Background: Incidence of primary bilateral breast cancer (BC) is rare and does not exceed 5%. BRCA1/2 mutation carriers diagnosed with breast cancer have a…”
Get full text

A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide by Kolaric, K, Bradamante, V, Cervek, J, Cieslinska, A, Cisarz-Filipcak, E, Denisov, L E, Donat, D, Drosik, K, Gershanovic, M, Hudziec, P

“…From January 1991 to August 1993, 237 women with metastatic breast cancer were recruited into a multicentric phase II clinical trial designed to assess the…”
Get more information

Stereospecific synthesis of chiral metabolites of ifosfamide and their determination in the urine by Misiura, K, Okruszek, A, Pankiewicz, K, Stec, W. J, Czownicki, Z, Utracka, B

“…The stereospecific synthesis of two chiral metabolites of ifosfamide (2), 4-ketoifosfamide (5) and 2-amino-3-(2-chloroethyl)tetrahydro-2H-1,3,…”
Get full text

Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis by QIANREN JIN, HEMMINKI, Kari, ZIENTEK, Helena, ROGOZINSKA-SZCZEPKA, Jadwiga, UTRACKA-HUTKA, Beata, HALLMANS, Göran, FÖRSTI, Asta, ENQUIST, Kerstin, LENNER, Per, GRZYBOWSKA, Ewa, KLAES, Rüdiger, HENRIKSSON, Roger, BOWANG CHEN, PAMULA, Jolanta, PEKALA, Wioletta

“…Purpose: Angiogenesis is a necessary step in tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is a major mediator of breast cancer…”
Get full text

Germline Mutations in BRCA1 and BRCA2 in Polish Families Predisposed to Breast and Ovary Cancers by Grzybowska, E., Jasinska, A., Kozlowski, P., Zientek, H., Krzyzosiak, W., Utracka-Hutka, B., Wloch, J., Rogozinska-Szczepka, J.

Get full text

Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers by Suwiński, R, Pilecki, B, Składowski, K, Swiatnicka, J, Zajusz, A, Przeorek, W, Utracka-Hutka, B, Jakus, G, Lange, B, Lange, D, Tarnawski, R, Maciejewski, B

“…Thirty-seven previously untreated patients with advanced, inoperable head and neck were treated with a sequential courses combining hypofractionated…”
Get full text

Navelbine (NVB) oral (o) with cisplatin (CDDP) as induction and concomitant to radiotherapy (RT): Final results of an international phase II trial in stage III non-small cell lung cancer (NSCLC) by Utracka-Hutka, B., Krzakowski, M., Provencio, M., Villa, E., Codes, M., Kuten, A., Riggi, M., Caux, N., Longerey, B., Dubray, B.

“…Abstract only 7691 Background: NVB i.v. with CDDP has reported an optimal activity/tolerance ratio when used in combination with RT. The new oral formulation…”
Get full text

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients by Rogozinska, J., Utracka-Hutka, B., Grzybowska, E., Nowicka, E., Maka, B., Steffen, J.

“…Abstract only…”
Get full text

BRCA1/2 mutations as prognostic factors in bilateral breast cancer (BC) patients by Rogozinska, J., Utracka-Hutka, B., Grzybowska, E., Nowicka, E., Maka, B., Steffen, J.

“…Abstract only…”
Get full text

Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer by Försti, Asta, Jin, Qianren, Grzybowska, Ewa, Söderberg, Magnus, Zientek, Helena, Sieminska, Marzena, Rogozinska-Szczepka, Jadwiga, Chmielik, Ewa, Utracka-Hutka, Beata, Hemminki, Kari

“…Ovarian steroids are one of the strongest risk factors for breast cancer. Sex hormone-binding globulin (SHBG) binds and transports sex steroids in the blood,…”
Get full text

Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study) by Pluzanska, A., Mainwaring, P., Cassidy, J., Utracka-Hutka, B., Zalucki, J., Glynne-Jones, R., Koralewski, P., Bridgewater, J., Wasan, H., Cunningham, D.

“…Abstract only…”
Get full text

271. Ocena wczesnych wyników leczenia oszczędzającego po neoadjuwantowej chemioterapii u kobiet na raka piersi kwalifikowanych pierwotnie po amputacji by Lange, B., Rogozińska-Szczepka, J., Mąka, B., Utracka, B., Jakus, G., Smok-Ragankiewicz, A.

“…Celem pracy jest ocena wyników leczenia oszczędzającego i skuteczności neoadjuvantowej chemioterapii dla obniżenia stopnia zaawansowania u chorych na lokalnie…”
Get full text

P-520 Navelbine oral with cisplatin as induction and concomitant to radiotherapy: A new option for the treatment of stage III non-small cell lung cancer (NSCLC) by Krzakowski, M., Provencio, M., Utracka-Hutka, B., Villa, E., Codes, M., Kuten, A., Fittipaldo, A., Caux, N., Longerey, B., Dubray, B.

Get full text

High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer by Grzybowska, Ewa, Zientek, Helena, Jasinska, Anna, Rusin, Marek, Kozlowski, Piotr, Sobczak, Krzysztof, Sikorska, Anna, Kwiatkowska, Eliza, Gorniak, Laura, Kalinowska, Ewa, Utracka-Hutka, Beata, Wloch, Jan, Chmielik, Ewa, Krzyzosiak, Wlodzimierz J.

“…Germ‐line mutations in BRCA1 and BRCA2 genes result in a significantly increased risk of breast and ovarian cancer. Other genes involved in an increased…”
Get full text

Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers by Jin, Qianren, Hemminki, Kari, Grzybowska, Ewa, Klaes, Rüdiger, Söderberg, Magnus, Zientek, Helena, Rogozinska-Szczepka, Jadwiga, Utracka-Hutka, Beata, Pamula, Jolanta, Pekala, Wioletta, Försti, Asta

“…Alterations in TGF-beta signaling appear to be associated with an altered risk of developing cancer, including breast cancer. We carried out a case-control…”
Get full text

Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population by Grzybowska, Ewa, Siemińska, Marzena, Zientek, Helena, Kalinowska, Ewa, Michalska, Jadwiga, Utracka-Hutka, Beata, Rogozińska-Szczepka, Jadwiga, Kaźmierczak-Maciejewska, Maria

“…Germline mutations in the BRCA1 or BRCA2 genes predispose their carriers to breast or/and ovary cancers during their lifetime. The most frequent mutations:…”
Get full text

488 Adjuvant radiotherapy in stage I ovarian cancer by Utracka Hutka, B., Kwaśniewska-Rokicińska, C., Smok, A.

“…The retrospective analysis of 141 patients with stage I ovarian cancer registered in the Institute of Oncology in Gliwice from January 1985 to December 1991…”
Get full text

408 New sequence variants, recurrent BRCA1/BRCA2 mutations and new aberrations in BRCA1 promoter region in breast and ovarian cancer cases from upper silesia in Poland by Pamula, J., Zientek, H., Sieminska, M., Pekala, W., Chmielik, E., Rogozinska-Szczepka, J., Utracka-Hutka, B., Rusin, M., Grzybowska, E.

Get full text

409 Clinical prognosis of BRCA1-associated breast cancer: a cohort study from the upper silesia region in Poland by Suwinski, R., Behrendt, K., Grzybowska, E., Zientek, H., Utracka-Hutka, B., Rogozinska-Szczepka, J., Kazimierczak-Maciejewska, M.

Get full text